Literature DB >> 15220739

Fungal keratitis caused by Paecilomyces lilacinus associated with a retained intracorneal hair.

Kent L Anderson1, Sandip Mitra, Ramin Salouti, Thu-Anh Pham, Hugh R Taylor.   

Abstract

OBJECTIVE: To report a case of fungal keratitis caused by Paecilomyces lilacinus (P. lilacinus) associated with a retained intracorneal hair.
METHODS: A 61-year-old man developed pain, decreased vision, hyperemia, and corneal infiltrates in his right eye without any predisposing factor. An intracorneal hair had migrated superiorly in the corneal stroma, giving rise to 3 separate stromal infiltrates. The patient demonstrated a waxing and waning course over several months despite antimicrobial and steroid therapy.
RESULTS: Histopathologic examination of a corneal biopsy specimen disclosed the presence of fungal elements, and intensive antifungal therapy was initiated. Verticillium sp. was initially identified as the causative organism, but after failure to improve on topical natamycin, subsequent investigations demonstrated the pathogen to be P. lilacinus that was resistant to routine antifungal agents. The patient was then initiated on systemic voriconazole and terbinafine. He responded well to treatment and ultimately recovered a best-corrected visual acuity of 6/15 in the affected eye.
CONCLUSION: This is the first case of P. lilacinus keratitis associated with a retained intracorneal hair. Hair in the cornea could be a predisposing factor for this infection. Early corneal biopsy should be considered to properly diagnose and manage atypical keratitis and to prevent further complications.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15220739     DOI: 10.1097/01.ico.0000114126.63670.4f

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  14 in total

1.  Successful treatment of Paecilomyces lilacinus keratitis with oral posaconazole.

Authors:  Michael A Arnoldner; Ahmad Kheirkhah; Frederick A Jakobiec; Marlene L Durand; Pedram Hamrah
Journal:  Cornea       Date:  2014-07       Impact factor: 2.651

2.  [Paecilomyces lilacinus keratitis].

Authors:  A-K B Maier; A Reichenbach; P Rieck
Journal:  Ophthalmologe       Date:  2011-10       Impact factor: 1.059

3.  Voriconazole concentration in human aqueous humor and plasma during topical or combined topical and systemic administration for fungal keratitis.

Authors:  Michael A Thiel; Annelies S Zinkernagel; Jürgen Burhenne; Claude Kaufmann; Walter E Haefeli
Journal:  Antimicrob Agents Chemother       Date:  2006-10-23       Impact factor: 5.191

4.  Recalcitrant Paecilomyces keratitis.

Authors:  Seetha Lakshmi; Cristina Vanessa Garcia
Journal:  BMJ Case Rep       Date:  2019-04-24

5.  A masquerader? Paecilomyces must be distinguished from Penicillium in fungal keratitis: a report of two contrasting cases.

Authors:  Arsham Sheybani; Alexander T Nguyen; George Harocopos; Anthony J Lubniewski; Andrew J W Huang
Journal:  BMJ Case Rep       Date:  2015-08-18

6.  Epidemiological profile of fungal keratitis in urban population of West Bengal, India.

Authors:  Suman Saha; Debdulal Banerjee; Archana Khetan; Jayangshu Sengupta
Journal:  Oman J Ophthalmol       Date:  2009-09

7.  Topical voriconazole therapy of Purpureocillium lilacinum keratitis that occurred in disposable soft contact lens wearers.

Authors:  Daisuke Todokoro; Norihiro Yamada; Mariko Fukuchi; Shoji Kishi
Journal:  Int Ophthalmol       Date:  2014-06-29       Impact factor: 2.031

8.  Topical and oral voriconazole in the treatment of fungal keratitis.

Authors:  Sang Joon Lee; Jung Joo Lee; Shin Dong Kim
Journal:  Korean J Ophthalmol       Date:  2009-03-09

9.  Update on terbinafine with a focus on dermatophytoses.

Authors:  Jason G Newland; Susan M Abdel-Rahman
Journal:  Clin Cosmet Investig Dermatol       Date:  2009-04-21

10.  Diversity of microbial species implicated in keratitis: a review.

Authors:  Elisabeth Karsten; Stephanie Lousie Watson; Leslie John Ray Foster
Journal:  Open Ophthalmol J       Date:  2012-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.